AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jbershad who wrote (1393)	6/3/1998 11:06:00 PM
From: arnie h	Read Replies (2) of 2173

Hi Jbershad: I like to check in every once in a while; so I thought I'd take a crack at answering your question about why the current weakness. Seems to me to be related to the Ergoset rejection. The 'Logic' for sellers would be something like this - "J&J ditched AMLN to hook up with Ergoset. Obviously, they think more of Ergoset's chances than of AMLN's. Ergoset gets turned down so, ergo, AMLN doesn't have much of a chance of getting approval". That's my guess and the fact that the whole market is heading south quickly doesn't help either. regards, Arnie alias Arnold (or vice versa).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next